US2153653A - Irradiated dusting powder - Google Patents

Irradiated dusting powder Download PDF

Info

Publication number
US2153653A
US2153653A US58227A US5822736A US2153653A US 2153653 A US2153653 A US 2153653A US 58227 A US58227 A US 58227A US 5822736 A US5822736 A US 5822736A US 2153653 A US2153653 A US 2153653A
Authority
US
United States
Prior art keywords
irradiated
dusting powder
gypsum
powder
anhydrite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US58227A
Inventor
Stux Gustav
Original Assignee
Stux Gustav
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT2153653X priority Critical
Application filed by Stux Gustav filed Critical Stux Gustav
Application granted granted Critical
Publication of US2153653A publication Critical patent/US2153653A/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Description

Patented Apr. 11,1939

UNITED STATES PATENT OFFICE IRRADIATED DUSTING POWDER Gustav Stux, Vienna, Austria No Drawing. Application January s, 1930, Serial No. 58,227. in Austria January 5, 1m

1 Claim.

This invention relates to irradiated dusting powder suitable more particularly for use in the to the action of chemically efi'ective light rays.

'Ihe yp um used may not be dead burned, and is pulverized extremely fine and purified before sterilization. For the purpose of sterilization the 15 powder is heated to about 100 C. preferably in a stirring or agitating devices. After having cooled down to about 60 0., the powder is then irradiated with-chemically potent rays, preferably by passing it under powerful quartz lamps in a thin layer spread out on conveyor belts. Instead of quartz lamps there can be employed any other lamps capable of'emitting ultra-violet rays.

In order to increase the efilcacy oi the dusting 25 powder produced in this manner, which, as already mentioned, is suitable not only for the treatment of the healthy skin but also for healing eczema, there can also be added to the powdered gypsum other specifically eifective sub- I 30 stances both of an inorganic and of an organic nature. This addition can be given either bei'ore, during, or alter the irradiatim with ultraviolet rays.. As an inorganic supplement there can be added for" example zinc oxide, which en- 35 hances the healing power, and as an organic,'pulverised camomile blossoms which likewise pro-- mote the healing of eczema and prevent irritatlon of the skin.

I have further found that skin irritation can be avoided entirely by using instead of gypsum amixture of gypsum and anhydrite. The term 5 anhydrite is to be understood as meaning both the natural mineral known as anhydrite and also artificial anhydrlte obtained by overburning gypsum. If a mixture of gypsum and anhydrlte be employed for the purpose of the present in- 10 vention an interaction is set up between the anhydrite and the hydrated gypsum, which does not 'exert the slightest irritation on the skin but which has a beneficial effect on herpes and discharging afi'ections and outbreaks. 'I'heefi'ect can be varied at will by altering the proportions of anhydrite and hydrated gypsum in the mixture.

It is known to use gypsum in the production of dusting powder (cl. Hager's "Handbuch der pharmazeutischen Praxis, Vol. I, 1925, page 766); the treatment of foodstuifs and remedial substances, such as fat, and lets and similar substances incorporated in ointments and creams containing or free from mineral additions, with 25 ultra-violet rays has likewise already been proposed (cf. Austrian Patents Nos. 118,782 and 121,657) It has been unknown as yet, however,

to treat dusting powder containing gypsum as the main constituent, with ultra-violet rays for 30 the purpose of enhancingits healing action I claim:

A: medicating dust-comprisinga mixture of roasted gypsum and anhydrlteirradiated by ultra-violet rays.

cus'rav s'rux

US58227A 1932-01-05 1936-01-08 Irradiated dusting powder Expired - Lifetime US2153653A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT2153653X 1932-01-05

Publications (1)

Publication Number Publication Date
US2153653A true US2153653A (en) 1939-04-11

Family

ID=3689977

Family Applications (1)

Application Number Title Priority Date Filing Date
US58227A Expired - Lifetime US2153653A (en) 1932-01-05 1936-01-08 Irradiated dusting powder

Country Status (1)

Country Link
US (1) US2153653A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2537530A (en) * 1947-10-30 1951-01-09 Hofman Emil Means for treating materials to kill bacteria, bacilli, and unsavory odors therein
US5032408A (en) * 1985-05-28 1991-07-16 Chemisch Adviesburea Drs. J.C.P. Schruder Composition for treatment of skin affections and process for its preparation
US20090176876A1 (en) * 2008-01-04 2009-07-09 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially decolletage
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7927614B2 (en) 2006-02-03 2011-04-19 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9427397B2 (en) 2009-01-23 2016-08-30 Obagi Medical Products, Inc. Rosacea treatments and kits for performing them

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2537530A (en) * 1947-10-30 1951-01-09 Hofman Emil Means for treating materials to kill bacteria, bacilli, and unsavory odors therein
US5032408A (en) * 1985-05-28 1991-07-16 Chemisch Adviesburea Drs. J.C.P. Schruder Composition for treatment of skin affections and process for its preparation
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7927614B2 (en) 2006-02-03 2011-04-19 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US8148563B2 (en) 2006-02-03 2012-04-03 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20090176876A1 (en) * 2008-01-04 2009-07-09 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially decolletage
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US8505730B2 (en) 2008-01-04 2013-08-13 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US9427397B2 (en) 2009-01-23 2016-08-30 Obagi Medical Products, Inc. Rosacea treatments and kits for performing them
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders

Similar Documents

Publication Publication Date Title
El-Kadre et al. Calcium metabolism in pre-and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass
THORPE et al. Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years
Gilman et al. The biological actions and therapeutic applications of the B-chloroethyl amines and sulfides
Guillemant et al. Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements
Hess et al. The cure of infantile rickets by artificial light and by sunlight
ES2099094T3 (en) Methods and compositions for treating pathological hydrophobic interactions in biological fluids.
Lachmann et al. Reaction mechanism of the alternative pathway of complement fixation
RO90639B (en) Process for preparing a human tissue plasminogene activator
JP3640215B2 (en) The composition of oak bark extract, methods related synthetic compositions and using the same
DE2005112B2 (en) Implant for surgical correction of heart valve defects
RO81616B (en) Silicone rubber mixture to be employed in vascular surgery
IE20010862A1 (en) Indole derivatives as 5-HT1 like agonists
Cohn Blood proteins and their therapeutic value
ES2134340T3 (en) Use of beta-hydroxy acid-beta-methylbutyric for promoting nitrogen retention in humans.
SE7605484A (en) Herdbar composition
MX165797B (en) Device for controlling the supply of an intraoral agent
Marshall et al. Puberty
ES2040257T3 (en) cosmetic composition.
MX9304435A (en) Compound and pharmaceutical composition for the treatment and prophylaxis of obesity or for the treatment of type II diabetes.
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
HK7785A (en) 3-alkylxanthines,process for their preparation and compositions for use in the treatment of chronic obstructive airway diseasse and cardiac disease
FR2301488A1 (en) Biocompatible glass ceramic and using this glass for manufacturing bone prostheses
Dixon et al. The effect of sensitization and x-radiation on the metabolism of I131 labeled proteins
Cooper et al. Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma
ES2063912T3 (en) immunogenic compositions against gastrin peptide.